240 results
Page 3 of 12
8-K
EX-99.1
g2dfvo 9f4kh0
22 Jun 21
Acasti Pharma Provides Fiscal 2021 Year-End Business Update
7:00am
8-K
EX-99.1
ocnr3og7q euypt
17 May 21
Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance
7:11am
8-K
EX-99.1
p7jdmdrao 5b
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-99.1
tv9it85xkqphkun6 lbb
7 May 21
Business combination disclosure
7:08am
8-K
EX-99.1
m8sihv0kf7p jysa
9 Mar 21
Acasti Pharma Provides Update on Recent Financing Activities
12:00am
8-K
EX-99.1
6gj3ps 6wrl
9 Feb 21
Acasti Pharma Announces Results for Third Quarter of Fiscal 2021
4:35pm
8-K
EX-99.1
wg9sv
27 Jan 21
Acasti Pharma Provides Update on Recent Financing Activities
7:35am
8-K
EX-99.1
jo8rnnzgbojsi
16 Nov 20
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
7:05am
8-K
EX-99.2
lplhigui
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-99.1
tysc8b32a3svrhbex1x
29 Sep 20
Acasti Announces Review Process of Strategic Alternatives
8:19am
8-K
EX-99.1
jnxov
17 Sep 20
Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
9:54pm
8-K
EX-99.1
gc1onqr26r4qjl
11 Sep 20
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
7:00am
DEFA14A
tqclcuiv dag5wrap6
11 Sep 20
Additional proxy soliciting materials
7:00am
DEF 14A
0llzl
9 Sep 20
Definitive proxy
4:00pm
8-K
EX-99.1
15wqqrk1h4cuvpls
31 Aug 20
Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia
4:05pm
8-K
EX-99.1
ugc6yl6ss v26mi4o
13 Aug 20
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
8:30am
PRE 14A
htkw7dyf
10 Aug 20
Preliminary proxy
12:00am
8-K
EX-99.1
th3jh 3hbpwkwe5duu
31 Jul 20
Regulation FD Disclosure
4:05pm
10-K
josxij
29 Jun 20
Annual report
4:02pm